Agios Pharmaceuticals IncNASDAQ:AGIO
- LAST PRICE59.0600
- TODAY'S CHANGE (%)3.9800 (7.2259%)
- Bid / Lots59.0000/ 1
- Ask / Lots94.8800/ 2
- Open / Previous Close54.3700 / 55.0800
- Day Range
- 52 Week Range
- Volume1,692,323
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AGIO |
|---|---|---|
| 09:32 ET | 27480 | 54.53 |
| 09:33 ET | 28625 | 54.505 |
| 09:35 ET | 12673 | 54.505 |
| 09:37 ET | 4172 | 54.98 |
| 09:39 ET | 36507 | 55.155 |
| 09:42 ET | 80300 | 55.02 |
| 09:44 ET | 11000 | 54.785 |
| 09:46 ET | 1465 | 55.14 |
| 09:48 ET | 3644 | 55.515 |
| 09:50 ET | 19810 | 55.855 |
| 09:51 ET | 100 | 55.86 |
| 09:53 ET | 26361 | 55.685 |
| 09:55 ET | 4699 | 55.695 |
| 09:57 ET | 10993 | 55.87 |
| 10:00 ET | 1200 | 55.82 |
| 10:02 ET | 1450 | 55.82 |
| 10:04 ET | 2262 | 55.925 |
| 10:06 ET | 13197 | 55.86 |
| 10:08 ET | 13083 | 55.7 |
| 10:09 ET | 4832 | 55.795 |
| 10:11 ET | 6679 | 55.94 |
| 10:13 ET | 2900 | 56.28 |
| 10:15 ET | 5800 | 56.33 |
| 10:18 ET | 300 | 56.1 |
| 10:20 ET | 1216 | 55.825 |
| 10:22 ET | 1081 | 55.835 |
| 10:24 ET | 1658 | 55.83 |
| 10:26 ET | 2124 | 55.825 |
| 10:27 ET | 1942 | 55.825 |
| 10:29 ET | 5198 | 56.055 |
| 10:31 ET | 2314 | 55.87 |
| 10:33 ET | 1600 | 56.01 |
| 10:36 ET | 15369 | 55.825 |
| 10:38 ET | 4940 | 55.96 |
| 10:40 ET | 16064 | 56.02 |
| 10:42 ET | 2882 | 56.06 |
| 10:44 ET | 1021 | 56.09 |
| 10:45 ET | 3998 | 56.395 |
| 10:47 ET | 8102 | 56.49 |
| 10:49 ET | 7144 | 56.685 |
| 10:51 ET | 900 | 56.69 |
| 10:54 ET | 1207 | 56.695 |
| 10:56 ET | 5148 | 56.705 |
| 10:58 ET | 2231 | 56.78 |
| 11:00 ET | 800 | 56.78 |
| 11:02 ET | 12862 | 56.9 |
| 11:03 ET | 3091 | 56.925 |
| 11:05 ET | 5396 | 56.845 |
| 11:07 ET | 12530 | 56.41 |
| 11:09 ET | 1805 | 56.075 |
| 11:12 ET | 1700 | 56.09 |
| 11:14 ET | 11257 | 56.1 |
| 11:16 ET | 1100 | 56.225 |
| 11:18 ET | 800 | 56.32 |
| 11:20 ET | 6482 | 56.53 |
| 11:21 ET | 2467 | 56.705 |
| 11:23 ET | 1794 | 56.8417 |
| 11:25 ET | 1100 | 56.645 |
| 11:27 ET | 4794 | 56.78 |
| 11:30 ET | 700 | 56.72 |
| 11:32 ET | 3962 | 56.795 |
| 11:34 ET | 600 | 56.63 |
| 11:36 ET | 400 | 56.76 |
| 11:38 ET | 200 | 56.72 |
| 11:39 ET | 2343 | 56.93 |
| 11:41 ET | 5004 | 57.0875 |
| 11:43 ET | 3658 | 57.35 |
| 11:45 ET | 500 | 57.405 |
| 11:48 ET | 2597 | 57.59 |
| 11:50 ET | 2326 | 57.73 |
| 11:52 ET | 7841 | 57.51 |
| 11:54 ET | 2200 | 57.005 |
| 11:56 ET | 500 | 56.98 |
| 11:57 ET | 1564 | 56.99 |
| 11:59 ET | 4063 | 57.16 |
| 12:01 ET | 1264 | 57.24 |
| 12:03 ET | 500 | 57.12 |
| 12:06 ET | 3301 | 57.094 |
| 12:08 ET | 400 | 57 |
| 12:10 ET | 6274 | 57.05 |
| 12:12 ET | 4164 | 57.165 |
| 12:14 ET | 1879 | 57.06 |
| 12:15 ET | 600 | 57.08 |
| 12:17 ET | 300 | 57.08 |
| 12:19 ET | 1687 | 57.1275 |
| 12:21 ET | 3063 | 57.44 |
| 12:24 ET | 1738 | 57.83 |
| 12:26 ET | 4921 | 57.89 |
| 12:28 ET | 500 | 58.08 |
| 12:30 ET | 2143 | 57.955 |
| 12:32 ET | 8482 | 58.04 |
| 12:33 ET | 1300 | 58.06 |
| 12:35 ET | 8144 | 58.04 |
| 12:37 ET | 4616 | 58.11 |
| 12:39 ET | 6079 | 58.13 |
| 12:42 ET | 1302 | 58.205 |
| 12:44 ET | 8379 | 58.37 |
| 12:46 ET | 1813 | 58.6 |
| 12:48 ET | 3994 | 58.45 |
| 12:50 ET | 2654 | 58.44 |
| 12:51 ET | 3005 | 58.54 |
| 12:53 ET | 2910 | 58.54 |
| 12:55 ET | 3249 | 58.93 |
| 12:57 ET | 2992 | 58.96 |
| 01:00 ET | 4403 | 59.15 |
| 01:02 ET | 4163 | 58.85 |
| 01:04 ET | 3618 | 58.975 |
| 01:06 ET | 506 | 59.01 |
| 01:08 ET | 9877 | 59.17 |
| 01:09 ET | 2600 | 59.36 |
| 01:11 ET | 450 | 59.32 |
| 01:13 ET | 4805 | 59.28 |
| 01:15 ET | 2180 | 59.2375 |
| 01:18 ET | 2177 | 59.3 |
| 01:20 ET | 4614 | 58.97 |
| 01:22 ET | 600 | 58.98 |
| 01:24 ET | 400 | 58.98 |
| 01:26 ET | 2935 | 58.99 |
| 01:27 ET | 1832 | 59.13 |
| 01:29 ET | 107837 | 58.95 |
| 01:31 ET | 1500 | 58.75 |
| 01:33 ET | 3141 | 59.1 |
| 01:36 ET | 700 | 59.115 |
| 01:38 ET | 2429 | 59 |
| 01:40 ET | 654 | 58.895 |
| 01:42 ET | 47510 | 58.915 |
| 01:44 ET | 1254 | 59.02 |
| 01:45 ET | 300 | 59.065 |
| 01:47 ET | 5230 | 59.55 |
| 01:49 ET | 2273 | 59.44 |
| 01:51 ET | 16689 | 59.32 |
| 01:54 ET | 400 | 59.37 |
| 01:56 ET | 500 | 59.375 |
| 01:58 ET | 2307 | 59.35 |
| 02:00 ET | 1264 | 59.16 |
| 02:02 ET | 2286 | 59.15 |
| 02:03 ET | 3382 | 59.14 |
| 02:05 ET | 1400 | 59.14 |
| 02:07 ET | 7416 | 58.86 |
| 02:09 ET | 5861 | 58.85 |
| 02:12 ET | 4179 | 58.87 |
| 02:14 ET | 376 | 58.84 |
| 02:16 ET | 2032 | 58.665 |
| 02:18 ET | 1229 | 58.67 |
| 02:20 ET | 700 | 58.665 |
| 02:21 ET | 700 | 58.67 |
| 02:23 ET | 1500 | 58.67 |
| 02:25 ET | 1404 | 58.675 |
| 02:27 ET | 7440 | 59.09 |
| 02:30 ET | 2355 | 59.21 |
| 02:32 ET | 1000 | 59.25 |
| 02:34 ET | 300 | 59.25 |
| 02:36 ET | 3107 | 59.44 |
| 02:38 ET | 4679 | 59.4675 |
| 02:39 ET | 1600 | 59.63 |
| 02:41 ET | 2006 | 59.76 |
| 02:43 ET | 1124 | 59.74 |
| 02:45 ET | 6655 | 59.9575 |
| 02:48 ET | 10729 | 60.18 |
| 02:50 ET | 5077 | 60.0856 |
| 02:52 ET | 3162 | 60.06 |
| 02:54 ET | 200 | 60 |
| 02:56 ET | 2722 | 59.815 |
| 02:57 ET | 1287 | 59.89 |
| 02:59 ET | 3721 | 59.56 |
| 03:01 ET | 5256 | 59.84 |
| 03:03 ET | 6385 | 60.04 |
| 03:06 ET | 3678 | 59.83 |
| 03:08 ET | 3387 | 59.57 |
| 03:10 ET | 1455 | 59.57 |
| 03:12 ET | 17360 | 59.385 |
| 03:14 ET | 7143 | 59.62 |
| 03:15 ET | 3279 | 59.81 |
| 03:17 ET | 5129 | 59.42 |
| 03:19 ET | 2303 | 59.29 |
| 03:21 ET | 1363 | 59.18 |
| 03:24 ET | 29865 | 59.155 |
| 03:26 ET | 3909 | 59.365 |
| 03:28 ET | 6677 | 59.21 |
| 03:30 ET | 5178 | 59.36 |
| 03:32 ET | 5040 | 59.352 |
| 03:33 ET | 2131 | 59.365 |
| 03:35 ET | 2608 | 59.19 |
| 03:37 ET | 3995 | 59.45 |
| 03:39 ET | 4481 | 59.525 |
| 03:42 ET | 3205 | 59.525 |
| 03:44 ET | 7200 | 59.53 |
| 03:46 ET | 4026 | 59.355 |
| 03:48 ET | 4096 | 59.39 |
| 03:50 ET | 2969 | 59.4 |
| 03:51 ET | 5959 | 59.315 |
| 03:53 ET | 13146 | 59.435 |
| 03:55 ET | 4679 | 59.17 |
| 03:57 ET | 18637 | 59.095 |
| 04:00 ET | 162853 | 59.06 |
Nov 5, 2024
Agios to Present New Data on Mitapivat and Tebapivat in Rare Blood Disorders at 66th ASH Annual Meeting and Exposition, from 9:05AM ET on Tuesday Nov 05, 2024 by Dow Jones
9:05AM ET on Tuesday Nov 05, 2024 by Dow Jones
Nov 1, 2024
DJ Agios Pharmaceuticals Price Target Maintained With a $55.00/Share by RBC Capital, from 12:43PM ET on Friday Nov 01, 2024 by Dow Jones
12:43PM ET on Friday Nov 01, 2024 by Dow JonesDJ Agios Pharmaceuticals Is Maintained at Sector Outperform by Scotiabank, from 10:30AM ET on Friday Nov 01, 2024 by Dow Jones
10:30AM ET on Friday Nov 01, 2024 by Dow Jones
Oct 31, 2024
*DJ Agios Pharmaceuticals 3Q EPS $16.22 >AGIO, from 6:30AM ET on Thursday Oct 31, 2024 by Dow Jones
6:30AM ET on Thursday Oct 31, 2024 by Dow JonesAgios Reports Business Highlights and Third Quarter 2024 Financial Results, from 6:30AM ET on Thursday Oct 31, 2024 by Dow Jones
6:30AM ET on Thursday Oct 31, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Agios Pharmaceuticals Inc | 3.4B | 4.8x | --- |
Xenon Pharmaceuticals Inc | 3.4B | -16.4x | --- |
Edgewise Therapeutics Inc | 3.4B | -23.7x | --- |
MoonLake Immunotherapeutics | 3.3B | -40.1x | --- |
Iovance Biotherapeutics Inc | 3.2B | -7.1x | --- |
Apogee Therapeutics Inc | 3.6B | -27.2x | --- |
Company Information
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its genetically defined disease (GDD) portfolio, PYRUKYND (Mitapivat), is an activator of both wild-type and a variety of mutant pyruvate kinase (PK) enzymes, for the treatment of hemolytic anemias. The Mitapivat is an orally available small molecule and a potent activator of the pyruvate kinase R (PKR) enzymes. In addition, it is also evaluating mitapivat for the treatment of alpha- and beta- thalassemia and sickle cell disease (SCD) in ongoing clinical trials. The Company is also developing AG-946, a clinical-stage oral activator of PKR enzymes for the treatment of hemolytic anemias and other indications, including SCD.
Contact Information
- Headquarters
- 88 Sidney StreetCAMBRIDGE, MA, United States 02139
- Phone
- 617-649-8600
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Jacqualyn Fouse
- Chief Executive Officer, Director
- Brian Goff
- Chief Financial Officer
- Cecilia Jones
- Chief Legal Officer
- James Burns
- Chief Medical Officer, Head - Research and Development
- Sarah Gheuens
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $3.4B |
|---|---|
Revenue (TTM) | $32.9M |
Shares Outstanding | 57.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.78 |
EPS | $12.28 |
Book Value | $14.50 |
P/E Ratio | 4.8x |
Price/Sales (TTM) | 102.5 |
Price/Cash Flow (TTM) | 4.6x |
Operating Margin | 2,075.26% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
